Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A With Inhibitor”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Post-approval studies (Phase 4)Looking for participantsNCT05888870
What this trial is testing

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

Who this might be right for
Hemophilia A With Inhibitor
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableNot Yet RecruitingNCT07200609
What this trial is testing

The Effects of Virtual Reality-Based Gamified Rehabilitation in Children With Hemophilia

Who this might be right for
Hemophilia A Without Inhibitor
Hacettepe University 20
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Post-approval studies (Phase 4)UnknownNCT03598725
What this trial is testing

Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China

Who this might be right for
Hemophilia A With Inhibitor
Beijing Children's Hospital 55
Large-scale testing (Phase 3)UnknownNCT06155955
What this trial is testing

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

Who this might be right for
Severe Hemophilia A Without InhibitorJoint Bleed
Chulalongkorn University 15
Not applicableStudy completedNCT03818529
What this trial is testing

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Who this might be right for
HemophiliaHemophilia AHemophilia B+5 more
American Thrombosis and Hemostasis Network 237
Not applicableUnknownNCT02554526
What this trial is testing

Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors

Who this might be right for
Hemophilia A With Inhibitor
Nara Medical University 10
Testing effectiveness (Phase 2)Study completedNCT06289166
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 25
Early research (Phase 1)UnknownNCT04768699
What this trial is testing

Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT00323856
What this trial is testing

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Grifols Biologicals, LLC 51
Testing effectiveness (Phase 2)Study completedNCT05619926
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04684940
What this trial is testing

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia A With Anti Factor VIII
BioMarin Pharmaceutical 10
Early research (Phase 1)Study completedNCT04072237
What this trial is testing

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Who this might be right for
Hemophilia AHemophilia BHemophilia A With Inhibitor+3 more
Catalyst Biosciences 11
Not applicableStudy completedNCT06357572
What this trial is testing

Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem

Who this might be right for
Hemophilia A With InhibitorHemophilia A
Enzyre B.V. 6
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Not applicableUnknownNCT01505946
What this trial is testing

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

Who this might be right for
Severe Hemophilia A With Inhibitor
Grifols Italia S.p.A 25
Not applicableUnknownNCT04106323
What this trial is testing

Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt

Who this might be right for
HemophiliaVon Willebrand DiseasesChristmas Disease
Safaa AA Khaled 100
Large-scale testing (Phase 3)Ended earlyNCT03588741
What this trial is testing

Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial

Who this might be right for
Haemophilia A
Novo Nordisk A/S 1
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 27
Post-approval studies (Phase 4)Looking for participantsNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95
Load More Results